All Stories

  1. Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory

    Article • Addiction, June 2018, Wiley

    Dr Chris Wilkins

  2. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand

    Article • Drug and Alcohol Review, December 2017, Wiley

    Dr Chris Wilkins

  3. Examining the differences between medical and recreational cannabis growers

    Article • Drugs Education Prevention and Policy, December 2017, Taylor & Francis

    Pekka Hakkarainen, Sharon Sznitman, Dr Chris Wilkins, Gary Potter, Tom Decorte

  4. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances (‘legal highs’) in New Zealand

    Article • Drug and Alcohol Review, February 2017, Wiley

    Dr Chris Wilkins

  5. Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for ‘low-risk’ psychoactive products in New Zealand?

    Article • Addiction, March 2015, Wiley

    Dr Chris Wilkins

  6. Recent developments with the establishment of a regulated legal market for new psychoactive substances (‘legal highs’) in New Zealand

    Article • Drug and Alcohol Review, October 2014, Wiley

    Dr Chris Wilkins

  7. Response to commentaries

    Article • Addiction, August 2014, Wiley

    Dr Chris Wilkins

  8. The interim regulated legal market for NPS (‘legal high’) products in New Zealand: The impact of new retail restrictions and product licensing

    Article • Drug Testing and Analysis, May 2014, Wiley

    Dr Chris Wilkins

  9. A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand

    Article • Addiction, February 2014, Wiley

    Dr Chris Wilkins